Skip to content

Investigation the effect of transcutaneous auricular vagus nerve stimulation on postpartum depression in pregnant women with depression tendency

Investigation the effect of transcutaneous auricular vagus nerve stimulation on postpartum depression in pregnant women with depression tendency

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600119584
Enrollment
Unknown
Registered
2026-02-28
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postpartum depression

Interventions

The taVNS group:Electrical stimulation was delivered through an electrode placed over the concha cavity of the left ear. In the active transcutaneous vagus nerve stimulation (taVNS) group, participant
frequency: 20 Hz) for 30 minutes, with current increasing progressively over 30 seconds until participants reported tingling, then decreasing to a level slightly below this threshold for 30 minutes.
Comfort stimulation group:In the comfort stimulation group, electrodes were placed similarly, and current was gradually increased for 30 s until participants reported tingling, then decreased to a lev

Sponsors

Hefei Maternal and Child Health Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Aged from 18 to 45 years old; 2. singleton pregnancy (37-42 weeks), elective cesarean section under spinal or combined spinal-epidural anesthesia; 3. No known fetal malformation or obvious abnormality; 4. American Society of Anesthesiologists (ASA) grade II-III; 5. Prenatal EPDS score =9; 6. Written informed consent; 7. Able to understand the content of the questionnaire and cooperate with the intervention and follow-up; 8. Did not participate in other studies.

Exclusion criteria

Exclusion criteria: 1. Those who have been diagnosed with severe mental illness during pregnancy or the postpartum period or are currently undergoing antidepressant treatment; 2. Combined with epilepsy, severe arrhythmia or with a pacemaker; 3. Ear infection, trauma or inability to wear stimulating electrodes; 4. Combined with other serious organic diseases or serious obstetric complications; 5. Contraindications for intraspinal puncture; 6. Follow-up for those who may be interrupted (such as those planning to live elsewhere).

Design outcomes

Primary

MeasureTime frame
Incidence of positive PPD screening at postnatal day 42 (6 weeks);

Secondary

MeasureTime frame
Incidence of positive PPD screening at 7 days (1 week) postpartum;Changes in EPDS total score ;VAS score ;Maternal anxiety score;Postpartum sleep quality;Quality of postpartum recovery;

Countries

China

Contacts

Public ContactWeijie Wang

West District of Hefei Maternal and Child Health Hospital

852194817@qq.com+86 187 5538 3073

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 9, 2026